Psychology & Psychiatry

Early MR scans found more people with broken-heart syndrome

In almost 10% of myocardial infarctions, no obvious cause in the coronary artery can be found. Some of the patients are diagnosed with broken-heart syndrome, while others are left without a diagnosis. A new study from Karolinska ...

Medications

Weekly semaglutide bests placebo for greater weight loss

(HealthDay)—Once-weekly subcutaneous semaglutide results in significantly greater weight loss than placebo when used as adjunctive therapy over 68 weeks in adults with overweight or obesity, according to a study published ...

Health

New Medicare benefit would limit insulin copays to $35 a month

Reacting to skyrocketing prices for insulin, the Trump Administration announced on Tuesday a new benefit that would limit Medicare recipients' copays for insulin to a maximum of $35 a month and save them about $446 a year ...

Medical research

New drug combination restores beta cell function in animal model

The loss of the identity of insulin-secreting beta cells in the islet of Langerhans, a process also called beta cell dedifferentiation, has been proposed to be a main reason for the development of diabetes. If and how dedifferentiated ...

Medical economics

Profits jab higher at insulin maker Novo Nordisk

Novo Nordisk said Friday that its new treatment for adults who suffer from diabetes drove sales and profits higher, but the world's top manufacturer of insulin still faced difficulties in the key US market.

Diabetes

Oral semaglutide reduces HbA1c, weight in patients with T2DM

(HealthDay)—Compared with placebo, oral semaglutide monotherapy is associated with superior and clinically relevant improvements in glycated hemoglobin (HbA1c) and weight loss among patients with type 2 diabetes, according ...

page 1 from 8